{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:03:45Z","timestamp":1785236625456,"version":"3.55.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The main objective of the present work was to dissect the interplay between penicillin-binding protein (PBP) occupancy, ampC transcriptional dynamics, and \u03b2-lactamase activity in Pseudomonas aeruginosa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using wild-type PAO1 and isogenic LMW-PBP knockout mutants (PAO\u0394dacB, PAO\u0394dacBdacC, and PAO\u0394dacBdacCpbpG), we assessed ampC induction following exposure to 18 \u03b2-lactams and \u03b2-lactamase inhibitors. PBP binding (IC50) was quantified via Bocillin-FL labelling. AmpC mRNA levels were measured by qRT-PCR, and \u03b2-lactamase activity was determined in crude extracts, periplasmic and extracellular fractions using nitrocefin and cefalotin substrates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Carbapenems and cefoxitin, the drugs that maximally inhibited PBP4, induced strong ampC transcription and \u03b2-lactamase activity, while ceftazidime, aztreonam, and penicillins (PBP3-binding) triggered mRNA upregulation without enzymatic output. Furthermore, LMW-PBP-deficient mutants showed stepwise ampC overexpression (up to \u223c7000-fold), but activity increases plateaued after \u223c1100-fold, even after a significant mRNA induction following incubation with ceftazidime.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings highlight that ampC transcription does not predict functional enzyme levels, especially for PBP3-binding drugs. Full induction appears to require PBP4 targeting and CreBC activation. These findings underscore the need for integrated assessment of PBP IC50, transcription, and enzymatic activity to guide rational \u03b2-lactam and \u03b2-lactamase inhibitor therapy, and lay the groundwork for future studies on alternative ampC regulatory pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkaf408","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:56:56Z","timestamp":1762649816000},"source":"Crossref","is-referenced-by-count":1,"title":["Unravelling the triad of penicillin-binding proteins, \u03b2-lactamase activity, and mRNA dynamics in\n                    <i>Pseudomonas aeruginosa<\/i>\n                    AmpC induction"],"prefix":"10.1093","volume":"81","author":[{"given":"Maria","family":"Montaner","sequence":"first","affiliation":[{"name":"Health Research Institute of the Balearic Islands (IdISBa) , Palma ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Montes","sequence":"additional","affiliation":[{"name":"Health Research Institute of the Balearic Islands (IdISBa) , Palma ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francina","family":"Alajarin","sequence":"additional","affiliation":[{"name":"Health Research Institute of the Balearic Islands (IdISBa) , Palma ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"L\u00f3pez-Arg\u00fcello","sequence":"additional","affiliation":[{"name":"Health Research Institute of the Balearic Islands (IdISBa) , Palma ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Oliver","sequence":"additional","affiliation":[{"name":"Health Research Institute of the Balearic Islands (IdISBa) , Palma ,","place":["Spain"]},{"name":"Servicio de Microbiolog\u00eda, Hospital Universitario Son Espases , Palma ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6404-246X","authenticated-orcid":false,"given":"Bartolome","family":"Moya","sequence":"additional","affiliation":[{"name":"Health Research Institute of the Balearic Islands (IdISBa) , Palma ,","place":["Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Infecciosas (CIBERINFEC) , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"2026011413270596400_dkaf408-B1","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1128\/AAC.00680-12","article-title":"Pan-\u03b2-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities","volume":"56","author":"Moy\u00e1","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B2","doi-asserted-by":"publisher","first-page":"e00524-19","DOI":"10.1128\/mSystems.00524-19","article-title":"Regulation of AmpC-driven \u03b2-lactam resistance in Pseudomonas aeruginosa: different pathways, different signaling","volume":"4","author":"Torrens","year":"2019","journal-title":"mSystems"},{"key":"2026011413270596400_dkaf408-B3","doi-asserted-by":"publisher","first-page":"e0014224","DOI":"10.1128\/spectrum.00142-24","article-title":"Ampc induction by imipenem in Pseudomonas aeruginosa occurs in the absence of OprD and impacts imipenem\/relebactam susceptibility","volume":"12","author":"Freed","year":"2024","journal-title":"Microbiol Spectr"},{"key":"2026011413270596400_dkaf408-B4","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1128\/AAC.01807-15","article-title":"Characterization of a carbapenem-hydrolyzing enzyme, PoxB, in Pseudomonas aeruginosa PAO1","volume":"60","author":"Zincke","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B5","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/jac\/dkab496","article-title":"Comparative analysis of in vitro dynamics and mechanisms of ceftolozane\/tazobactam and imipenem\/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones","volume":"77","author":"Gomis-Font","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2026011413270596400_dkaf408-B6","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1128\/AAC.41.9.2013","article-title":"Penicillin-binding proteins and induction of AmpC beta-lactamase","volume":"41","author":"Sanders","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B7","doi-asserted-by":"publisher","first-page":"e0201921","DOI":"10.1128\/spectrum.02019-21","article-title":"Impact of peptidoglycan recycling blockade and expression of horizontally acquired \u03b2-lactamases on Pseudomonas aeruginosa virulence","volume":"10","author":"Barcel\u00f3","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2026011413270596400_dkaf408-B8","doi-asserted-by":"publisher","first-page":"e01783-16","DOI":"10.1128\/mBio.01783-16","article-title":"Impact of AmpC derepression on fitness and virulence: the mechanism or the pathway?","volume":"7","author":"P\u00e9rez-Gallego","year":"2016","journal-title":"mBio"},{"key":"2026011413270596400_dkaf408-B9","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1128\/AAC.00385-10","article-title":"Nagz inactivation prevents and reverts beta-lactam resistance, driven by AmpD and PBP4 mutations, in Pseudomonas aeruginosa","volume":"54","author":"Zamorano","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B10","doi-asserted-by":"publisher","first-page":"e1000353","DOI":"10.1371\/journal.ppat.1000353","article-title":"Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein","volume":"5","author":"Moya","year":"2009","journal-title":"PLoS Pathog"},{"key":"2026011413270596400_dkaf408-B11","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1128\/AAC.05150-14","article-title":"Role of Pseudomonas aeruginosa low-molecular-mass penicillin-binding proteins in AmpC expression, beta-lactam resistance, and peptidoglycan structure","volume":"59","author":"Ropy","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B12","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1128\/AAC.50.5.1780-1787.2006","article-title":"Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues","volume":"50","author":"Juan","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B13","doi-asserted-by":"publisher","first-page":"e0303822","DOI":"10.1128\/spectrum.03038-22","article-title":"PBP target profiling by \u03b2-lactam and \u03b2-lactamase inhibitors in intact Pseudomonas aeruginosa: effects of the intrinsic and acquired resistance determinants on the periplasmic drug availability","volume":"11","author":"Montaner","year":"2023","journal-title":"Microbiol Spectr"},{"key":"2026011413270596400_dkaf408-B14","doi-asserted-by":"publisher","first-page":"e0160322","DOI":"10.1128\/aac.01603-22","article-title":"Penicillin-binding protein 5\/6 acting as a decoy target in Pseudomonas aeruginosa identified by whole-cell receptor binding and quantitative systems pharmacology","volume":"67","author":"L\u00f3pez-Arg\u00fcello","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B15","doi-asserted-by":"publisher","first-page":"e0270022","DOI":"10.1128\/spectrum.02700-22","article-title":"Role of enzymatic activity in the biological cost associated with the production of AmpC \u03b2-lactamases in Pseudomonas aeruginosa","volume":"10","author":"Barcel\u00f3","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2026011413270596400_dkaf408-B16","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.1128\/AAC.49.11.4733-4738.2005","article-title":"Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains","volume":"49","author":"Juan","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B17","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.3390\/ijms22063051","article-title":"Molecular basis of AmpC \u03b2-lactamase induction by avibactam in Pseudomonas aeruginosa: PBP occupancy, live cell binding dynamics and impact on resistant clinical isolates harboring PDC-X variants","volume":"22","author":"L\u00f3pez-Arg\u00fcello","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026011413270596400_dkaf408-B18","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.1128\/AAC.01729-15","article-title":"Complex regulation pathways of AmpC-mediated \u03b2-lactam resistance in Enterobacter cloacae complex","volume":"59","author":"Gu\u00e9rin","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1574-6976.2007.00099.x","article-title":"Bacterial peptidoglycan (murein) hydrolases","volume":"32","author":"Vollmer","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"2026011413270596400_dkaf408-B20","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1128\/AAC.02556-14","article-title":"The Pseudomonas aeruginosa CreBC two-component system plays a major role in the response to \u03b2-lactams, fitness, biofilm growth, and global regulation","volume":"58","author":"Zamorano","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B21","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1093\/jac\/dkab213","article-title":"In vitro evolution of cefepime\/zidebactam (WCK 5222) resistance in Pseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact on in vivo efficacy","volume":"76","author":"Barcel\u00f3","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2026011413270596400_dkaf408-B22","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/cid\/ciz173","article-title":"A primer on AmpC \u03b2-lactamases: necessary knowledge for an increasingly multidrug-resistant world","volume":"69","author":"Tamma","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026011413270596400_dkaf408-B23","author":"CLSI"},{"key":"2026011413270596400_dkaf408-B24","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"2026011413270596400_dkaf408-B25","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1128\/AAC.43.4.862","article-title":"Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes","volume":"43","author":"Oliver","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B26","doi-asserted-by":"publisher","first-page":"116356","DOI":"10.1016\/j.diagmicrobio.2024.116356","article-title":"Characterisation of a novel AmpC beta-lactamase, DHA-33, resistant to inhibition by cloxacillin","volume":"109","author":"Findlay","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026011413270596400_dkaf408-B27","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/pmic.200800618","article-title":"Analysis of the periplasmic proteome of Pseudomonas aeruginosa, a metabolically versatile opportunistic pathogen","volume":"9","author":"Imperi","year":"2009","journal-title":"Proteomics"},{"key":"2026011413270596400_dkaf408-B28","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1128\/AAC.00519-11","article-title":"Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth","volume":"55","author":"Mulet","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2958.2006.05366.x","article-title":"PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa","volume":"62","author":"Bl\u00e1zquez","year":"2006","journal-title":"Mol Microbiol"},{"key":"2026011413270596400_dkaf408-B30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1126\/science.1188308","article-title":"Quantifying E. coli proteome and transcriptome with single-molecule sensitivity in single cells","volume":"329","author":"Taniguchi","year":"2010","journal-title":"Science"},{"key":"2026011413270596400_dkaf408-B31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/CMR.8.4.557","article-title":"Beta-lactamases in laboratory and clinical resistance","volume":"8","author":"Livermore","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"2026011413270596400_dkaf408-B32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"Ampc beta-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"2026011413270596400_dkaf408-B33","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/jac\/dkq142","article-title":"Differential beta-lactam resistance response driven by ampD or dacB (PBP4) inactivation in genetically diverse Pseudomonas aeruginosa strains","volume":"65","author":"Zamorano","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2026011413270596400_dkaf408-B34","doi-asserted-by":"publisher","first-page":"e01651-16","DOI":"10.1128\/AAC.01651-16","article-title":"Penicillin-binding protein 3 is essential for growth of Pseudomonas aeruginosa","volume":"61","author":"Chen","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B35","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/CMR.00043-12","article-title":"Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance","volume":"25","author":"Fern\u00e1ndez","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"2026011413270596400_dkaf408-B36","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1128\/AAC.40.5.1289","article-title":"Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins","volume":"40","author":"Fung-Tomc","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/jac\/8.suppl_B.147","article-title":"Susceptibility of ceftazidime and other cephalosporins to a range of beta-lactamases and their potential as inducing agents","volume":"8","author":"Mouton","year":"1981","journal-title":"J Antimicrob Chemother"},{"key":"2026011413270596400_dkaf408-B38","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1128\/AAC.43.4.882","article-title":"Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin","volume":"43","author":"Lister","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B39","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1093\/jac\/dkx298","article-title":"Ampc \u03b2-lactamase induction by avibactam and relebactam","volume":"72","author":"Livermore","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2026011413270596400_dkaf408-B40","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1128\/AAC.03057-14","article-title":"Avibactam and class C \u03b2-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance","volume":"58","author":"Lahiri","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2026011413270596400_dkaf408-B41","doi-asserted-by":"publisher","first-page":"11663","DOI":"10.1073\/pnas.1205073109","article-title":"Avibactam is a covalent, reversible, non-\u03b2-lactam \u03b2-lactamase inhibitor","volume":"109","author":"Ehmann","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026011413270596400_dkaf408-B42","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/jac\/dkn320","article-title":"NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases","volume":"62","author":"Livermore","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2026011413270596400_dkaf408-B43","doi-asserted-by":"publisher","first-page":"e0141924","DOI":"10.1128\/mbio.01419-24","article-title":"A potential space-making role in cell wall biogenesis for SltB1and DacB revealed by a beta-lactamase induction phenotype in Pseudomonas aeruginosa","volume":"15","author":"Gyger","year":"2024","journal-title":"mBio"},{"key":"2026011413270596400_dkaf408-B44","doi-asserted-by":"publisher","first-page":"e0298224","DOI":"10.1128\/mbio.02982-24","article-title":"Progression of ampC amplification during de novo amoxicillin resistance development in E. coli","volume":"16","author":"Nong","year":"2025","journal-title":"mBio"},{"key":"2026011413270596400_dkaf408-B45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1179\/1973947813Y.0000000119","article-title":"The extended-spectrum AmpC genotype of Pseudomonas aeruginosa strains from Egypt: an underlying threat to anti-pseudomonal treatment options","volume":"26","author":"El-Mahdy","year":"2014","journal-title":"J Chemother"},{"key":"2026011413270596400_dkaf408-B46","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0092-8674(00)81928-5","article-title":"Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in gram-negative bacteria","volume":"88","author":"Jacobs","year":"1997","journal-title":"Cell"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/1\/dkaf408\/65224122\/dkaf408.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/1\/dkaf408\/65224122\/dkaf408.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:27:16Z","timestamp":1768415236000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkaf408\/8314987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaf408","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,11,5]]},"article-number":"dkaf408"}}